Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0LG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,052
Award facts
- Contract value 100% obligated
- $26,052.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,052.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. The contract is unset-aside and competitively awarded, with a completion date of January 14, 2026, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of medications and medical supplies through the DLA Medical Supply Chain. The company's federal contracting demonstrates significant capacity to fulfill government medical procurement requirements across multiple therapeutic domains, including the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities that support military treatment facilities and Defense Health Agency operations worldwide. This delivery order for RINVOQ ER tablets represents a routine pharmaceutical supply transaction within the broader strategic partnership between Cencora, Inc. and the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FR0LG?
SPE2DR26FR0LG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FR0LG worth?
The government has obligated $26,052 on SPE2DR26FR0LG.
Is contract SPE2DR26FR0LG an order under another contract?
Yes. SPE2DR26FR0LG is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0LG competed?
The extent of competition for SPE2DR26FR0LG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award